Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Amantadine

A derivative of adamantane, a cage-shaped molecule, approved in the United States in the 1960s as an antiviral against influenza A and also used in Parkinson's disease. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?Its anti-Parkinson effect was discovered by chance in the late 1960s: a patient taking it for flu noticed that her tremor and stiffness improved, then worsened again when she finished the course.

AmantadineGo to the active ingredient →
AmantadineActive ingredientAmantadineCat. No. P-A104-001CAS 768-94-5
Amantadine-d15Isotopically labelledAmantadine-d15Cat. No. P-A104-005CAS 33830-10-3
Amantadine-d6Isotopically labelledAmantadine-d6Cat. No. P-A104-006CAS 1219805-53-4
AdamantaneImpurityAdamantaneCat. No. P-A104-025CAS 281-23-2

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.